Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-26

Clinical Trial Update: Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH [Phase 1]

View source ↗

Summary

This update notes the termination of a Phase 1 safety and pharmacokinetic trial comparing intracisternal EG-1962 to enteral nimodipine in adults with aneurysmal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EG-1962
  • Nimodipine (Nimodipine)

Snippet

Sponsor: Edge Therapeutics Inc | Conditions: Subarachnoid Hemorrhage, Aneurysmal | Phase 1 | Status: TERMINATED